logo
Select company
Select metric
$ 114.69MNet Cash Flow - Financing
VS
Market
16
Sector
12
Industry
15
History
-
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information

Ticker

CRMD

Company Name

CORMEDIX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CORMEDIX INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRMD - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 114.69M
3/31/2025$ 32.51M
12/31/2024$ 26.32M
9/30/2024$ 15.5M
6/30/2024$ 44.33M
3/31/2024$ 48.62M
12/31/2023$ 55.92M
9/30/2023$ 61.49M
6/30/2023$ 19.03M
3/31/2023$ 22.09M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CORMEDIX INC's latest trailing twelve months (TTM) CF - Financing stands at $ 24.57M.
  • Over the past 5 years, CORMEDIX INC's average CF - Financing has been $ 40.31M.
  • The median CF - Financing for CORMEDIX INC during this period was $ 36.3M
  • CORMEDIX INC reached its highest CF - Financing over the past 5 years at $ 114.69M.
  • The lowest CF - Financing recorded by CORMEDIX INC in the same timeframe $ 3.18M

CORMEDIX INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
NAGE : NIAGEN BIOSCIENCE INC $ 11.63MZYME : ZYMEWORKS INC $ -20.99MANAB : ANAPTYSBIO INC $ 19.71MPHAT : PHATHOM PHARMACEUTICALS INC $ 148.18MURGN : UROGEN PHARMA LTD $ 40.01MGYRE : GYRE THERAPEUTICS INC $ 24.98MNRIX : NURIX THERAPEUTICS INC $ 203.16MGERN : GERON CORP $ 171.09MSNDX : SYNDAX PHARMACEUTICALS INC $ 352MXNCR : XENCOR INC $ 196.21M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

CRMD - Net Cash Flow - Financing, Last 5 years

$ 3.18M

Minimum

Mar 31, 2022

$ 114.69M

Maximum

Jun 30, 2025

$ 40.31M

Average

$ 36.3M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.89M with a standard deviation of $ 118.55M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -365.75M
max$ 365M
average$ -6.89M
median$ 314K
std$ 118.55M